Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
iobenguane I-131
|
| gptkbp:approvalYear |
2018
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:containsRadioisotope |
gptkb:Iodine-131
|
| https://www.w3.org/2000/01/rdf-schema#label |
Azedra
|
| gptkbp:indication |
gptkb:pheochromocytoma
paraganglioma |
| gptkbp:manufacturer |
gptkb:Progenics_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
targets neuroendocrine tumors
|
| gptkbp:orphanDrugStatus |
yes
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:usedFor |
treatment of rare adrenal tumors
|
| gptkbp:bfsParent |
gptkb:Progenics_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|